




Resistance to  
Transient Rifampin 
Exposure
To the Editor: We read with 
interest the discussion between de 
Steenwinkel et al. and Werngren (1) 
regarding the high mutation frequen-
cies de Steenwinkel et al. reported for 
some Mycobacterium tuberculosis 
strains (2). We investigated the effect 
of rifampin exposure on the growth of 
these strains in detail.
We share Werngren’s surprise at 
the extraordinary mutation frequen-
cies observed for the Beijing strains. 
We previously estimated the mutation 
rate of 1 of the strains tested at ≈1 × 
10–7 (3), which is within the range 
typically reported for acquisition of 
rifampin resistance by strains from 
Beijing and other lineages of M. tu-
berculosis (4,5). Several explanations 
were proposed for the detection of a 
high frequency of mutants on rifampin 
exposure, mainly related to methods 
or experimental variation (1). We pro-
pose an alternative interpretation of 
these findings on the basis of new ex-
perimental data (Figure). 
These data show that some M. tu-
berculosis strains persist longer than 
others after transient exposure to low 
concentrations of rifampin, which 
could create a wider window for the 
(possibly stimulated) generation and 
selection of resistant mutants. Thus, 
the frequency of 10–3 resistant CFUs 
selected on rifampin may represent 
not the frequency of preexisting mu-
tants but rather frequency of mutants 
generated by a population of persist-
ing (stressed) cells during exposure to 
low levels of antimicrobial drugs. We 
investigated the effect of transient ex-
posure to rifampin on colony growth 
rate and post–antimicrobial drug 
outgrowth on a panel of Beijing and 
non-Beijing M. tuberculosis strains, 
including some studied in the work of 
Steenwinkel et al. (2). We used a cul-
ture method developed on the basis of 
den Hertog et al. (6) but with higher 
throughput and improved imaging and 
analysis, in which individual colonies 
are monitored over time and growing 
colonies can be moved from 1 solid 
medium to another. 
We injected ≈5 × 104 CFUs of 
M. tuberculosis per cm2, consisting 
mostly of single cells (6), on porous 
aluminum oxide supports (PAOs) 
on MB7H11 agar + OADC (Becton 
Dickinson, Sparks, MD, USA). After 
8 days’ incubation at 36°C, the PAOs 
containing microcolonies consisting 
of ≈200 cells were moved onto me-
dium containing 0.5–2 µg/mL of ri-
fampin for 4 h, after which the PAOs 
were returned to nonselective medi-
um. Filters were monitored for colony 
growth by using a MuScan microscop-
ic system (LumiByte BV, Nuenen, the 
Netherlands) at 5× magnification; a 
≈0.44-cm2 area was imaged at specific 
intervals before and after exposure to 
rifampin. We used Fiji (http://fiji.sc/
Fiji) and in-house software (6) to ex-
tract the surface areas of all identified 
colonies at all available time points; 
individual growth rates could thus be 
calculated for all colonies. In total, 
36,408 colonies were defined as ob-
jects with a growth rate of >20% from 
days 6 and 8 after inoculation with 
>0.5 circularity.
As shown in the Figure, the 
growth of non-Beijing strains stud-
ied (East African/Indian strains and 
strain H37Ra) was almost completely 
inhibited during the first 24 hours af-
ter rifampin exposure. In contrast, all 
the Beijing genotype strains studied 
showed residual growth in most colo-
nies in the first 24 hours after rifampin 
exposure. At 1–5 days postexposure, 
the pattern remained the same; the 
Beijing strain colonies were more ca-
pable of persisting and exhibited slow 














to low concentrations of rifampin. To 
confirm that this effect was a result 
of persistence rather than generation 
of resistant mutants, we transferred 
the colonies growing after transient 
rifampin exposure of Beijing strain 
1585 to a medium containing 8 mg/L 
rifampin. Their growth was complete-
ly inhibited, and molecular analysis 
did not detect any of the most preva-
lent rifampin resistance–associated 
mutants (data not shown).
We believe that these results pro-
vide a possible explanation for the 
otherwise unrealistically high (ap-
parent) mutation frequency reported 
by de Steenwinkel et al. (2). If these 
strains are capable of persisting at 
low concentrations of rifampin, this 
extended period would provide a 
window for the generation of mutants 
during or after exposure. Stress may 
also play a role; rpoB gene mutants 
have shown to exhibit a stringent-like 
response (7), and defective rpoB ac-
tivity as a result of low-level rifampin 
exposure could induce a similar re-
sponse. If rifampin induces a stress 
response, the situation may be analo-
gous to the high mutation rates seen 
after quinolone exposure (8).
In summary, our data show that 
the high apparent M. tuberculosis strain 
mutation frequency reported by de 
Steenwinkel et al. (2) may be a result 
of the higher tolerance to rifampin of 
some Beijing strains. This tolerance 
likely results in a specific window of 
rifampin concentrations that, possibly 
combined with subsequent error-prone 
replication/outgrowth, enables the gen-
eration and selection of new mutants, 
rather than the selection of preexisting 
mutants. When interpreted in the light 
of our observations, the unexpected re-
sults of de Steenwinkel et al. could help 
explain the association of Beijing gen-
otype strains with drug resistance and 
relapse (9,10). Drug levels achieved 
during treatment may be much more 
critical in preventing the accumulation 
of rifampin-resistant mutants for these 
strains than for other genotypes.
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Bacteria in  
Dairy Products  
in Baggage  
of Incoming  
Travelers, Brazil
To the Editor: International air 
travel can lead to the rapid global 
dissemination of infectious agents. 
Unlike products and byproducts of 
animal origin imported between coun-
tries under agreements that legally 
establish sanitary standards, products 
introduced into a country illegally or 
irregularly do not follow specific stan-
dards and can come from any source, 
thereby posing a risk to the health 
